Page last updated: 2024-11-05

talactoferrin alfa and Local Neoplasm Recurrence

talactoferrin alfa has been researched along with Local Neoplasm Recurrence in 1 studies

talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006

Research Excerpts

ExcerptRelevanceReference
"Talactoferrin alfa (TLF) is a unique recombinant form of human lactoferrin."1.40Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients. ( Bhattacharya, N; Blenman, KR; Engleman, E; Hwang, G; Lee, PP; Malik, R; Neal, JW; Pultar, P; Riess, JW; San-Pedro Salcedo, M; Wakelee, HA, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Riess, JW1
Bhattacharya, N1
Blenman, KR1
Neal, JW1
Hwang, G1
Pultar, P1
San-Pedro Salcedo, M1
Engleman, E1
Lee, PP1
Malik, R1
Wakelee, HA1

Other Studies

1 other study available for talactoferrin alfa and Local Neoplasm Recurrence

ArticleYear
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients.
    Immunopharmacology and immunotoxicology, 2014, Volume: 36, Issue:2

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lactoferrin; Lung Neoplasms; Male; Middle Aged

2014